[Form 4] The Cigna Group Insider Trading Activity
Nicole S. Jones, EVP, Chief Administrative Officer and General Counsel of The Cigna Group (CI), reported multiple transactions under a Rule 10b5-1 plan.
Rhea-AI Filing Summary
Nicole S. Jones, EVP, Chief Administrative Officer and General Counsel of The Cigna Group (CI), reported multiple transactions under a Rule 10b5-1 plan. On 08/15/2025 and 08/18/2025 she executed option exercises and open-market trades: option-related acquisitions of 13,155 and 11,598 shares at exercise prices of $197.35 and $183.4405, additional option exercises of 1,348 and 1,329 shares, and a reported sale of 28,526 shares at $300 on 08/15/2025. Following these transactions her reported beneficial ownership positions changed across reported lines (examples shown: 42,576; 54,174; 25,648; 26,996; 28,325). She also holds 1,419.6518 shares indirectly via the company 401(k) plan. The Form 4 states the trades were effected pursuant to a 10b5-1 plan adopted May 8, 2025, and lists Tyler Gratton as attorney-in-fact who signed the filing on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider executed option exercises and a sizeable sale under a pre-established 10b5-1 plan; transactions are material to insider holdings.
The reported Form 4 shows simultaneous option exercises and an open-market sale on 08/15/2025 with follow-up option-related purchases on 08/18/2025. The sale of 28,526 shares at $300 is the largest single disposition disclosed and meaningfully alters reported direct holdings on the form. The filing explicitly identifies the trades as pursuant to a Rule 10b5-1 plan adopted 05/08/2025, which documents pre-arranged timing and may limit contemporaneous trading interpretation. All figures and dates are taken directly from the filing.
TL;DR: Transactions were executed under a 10b5-1 plan and include option exercises and 401(k) participation; procedural disclosures appear complete.
The Form 4 discloses option exercises at stated exercise prices ($183.4405 and $197.35), purchases reported as resulting from those exercises, and indirect ownership via the 401(k). The filing includes the 10b5-1 adoption date and an attorney-in-fact signature, consistent with standard insider reporting practices. The report lists Jones's corporate title and relationship to the issuer, meeting disclosure requirements shown in the document.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to Buy) | 1,348 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to Buy) | 1,329 | $0.00 | $0.00 |
| Exercise | Common Stock, $.01 Par Value | 1,348 | $183.4405 | $247K |
| Exercise | Common Stock, $.01 Par Value | 1,329 | $197.35 | $262K |
| Exercise | Employee Stock Option (Right to Buy) | 11,598 | $0.00 | $0.00 |
| Exercise | Employee Stock Option (Right to Buy) | 13,155 | $0.00 | $0.00 |
| Exercise | Common Stock, $.01 Par Value | 13,155 | $197.35 | $2.60M |
| Exercise | Common Stock, $.01 Par Value | 11,598 | $183.4405 | $2.13M |
| Sale | Common Stock, $.01 Par Value | 28,526 | $300.00 | $8.56M |
| holding | Common Stock, $.01 Par Value | -- | -- | -- |
Footnotes (4)
- F1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2025.
- F2. Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
- F3. This option was granted on February 27, 2019. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.
- F4. This option was granted on February 28, 2018. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
